ConductScience.org, home

Paper427147

Effect of fetal calf serum and serum protein fractions on the uptake of liposomal phosphatidylcholine by rat hepatocytes in primary monolayer culture.

Hoekstra D and 1 other. Biochim Biophys Acta, 1979. Cited by 63 papers, by iCite.

Cite this record

ConductScience Library. Effect of fetal calf serum and serum protein fractions on the uptake of liposomal phosphatidylcholine by rat hepatocytes in primary monolayer culture. Papers, record 427147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/427147

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of fetal calf serum and serum protein fractions on the uptake of liposomal phosphatidylcholine by rat hepatocytes in primary monolayer culture.
PubMed
Journal
Biochim Biophys Acta
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
63
iCite
Relative citation ratio, by iCite
1.75
iCite
Revised in PubMed
2019-06-09
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hoekstra DD
2Scherphof GG

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
LiposomesMajor topic
LiverMajor topic
PhosphatidylcholinesMajor topic
Animals
Biological Transport
Blood
Blood Proteins
Cattle
Cells, Cultured
Culture Media
Immunoelectrophoresis
Kinetics
Lipoproteins
Rats

Source PubMed

Download CSV of topics

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 63 citations.

PMIDTitleJournalYearIn PapersSource
37554660Recent Advances in Messenger Ribonucleic Acid (mRNA) Vaccines and Their Delivery Systems: A Review.Clin Pharmacol2023https://conductscience.org/library/papers/37554660PubMed
34683969Lipid Nanoparticles for Organ-Specific mRNA Therapeutic Delivery.Pharmaceutics2021https://conductscience.org/library/papers/34683969PubMed
26462242Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies.Breast Cancer (Auckl)2015https://conductscience.org/library/papers/26462242PubMed
25786618Lipid nanoparticle delivery systems for siRNA-based therapeutics.Drug Deliv Transl Res2014https://conductscience.org/library/papers/25786618PubMed
7037620Immune response mediated by liposome-associated protein antigens. I. Potentiation of the plaque-forming cell response.Immunology1982https://conductscience.org/library/papers/7037620PubMed
2965295Liposomes in chemo- and immunotherapy of cancer.Lipids1987https://conductscience.org/library/papers/2965295PubMed
2719665Entrapment of high-molecular-mass DNA molecules in liposomes for the genetic transformation of animal cells.Biochem J1989https://conductscience.org/library/papers/2719665PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/427147

GET https://conductscience.org/api/papers/v1/427147/authors